PM
PharmaCyte Biotech, Inc.
PMCB · NASDAQ
$0.45 +8.08% (+$0.03)
1M -13.75%
Market Cap $4.41M
P/E Ratio -
Div. Yield -
ROE 60.42%
Piotroski F-Score Weak
2/9Valuation
90 /100
Cheap P/B 1.91x
P/E N/A
EV/EBITDA N/A
Growth
100 /100
Growing Book val. growth 2,751.79%
EPS growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
0 /100
Poor ROIC 83.13%
ROE 60.42%
ROA 45.90%
Debt
100 /100
Low Debt/Equity 0.00x
Current ratio 40.30x
Int. coverage N/A
Stability
37 /100
Moderate Beta 0.66x
EPS volatility 250.18%
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre PMCB
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Joshua N. Silverman
Employees
2
Headquarters
Las Vegas
Evenimente viitoare
16 DEC.
Earnings
Upcoming earnings report